<!doctype html>
<html class="no-js" lang="en">
<head>
	<meta charset="utf-8" />
	<meta name="viewport" content="width=device-width, initial-scale=1.0" />
	<meta name="keywords" content="News, WavoDyne Therapeutics, Scientific Publications Harris Gelbard Neuroinflammatory," />
	<meta name="description" content="Lead scientist Dr. Harris Gelbard is the author of over 100 scientific publications and has received over $29 mm in Federal research funding to date. WavoDyne maintains an ongoing collaboration with Dr. Gelbard">


	<title>News | WavoDyne Therapeutics</title>
	<link rel="stylesheet" href="stylesheets/app.css" />
	<script src="bower_components/modernizr/modernizr.js"></script>

	<link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css">

	<link rel="apple-touch-icon" sizes="57x57" href="/apple-touch-icon-57x57.png">
	<link rel="apple-touch-icon" sizes="60x60" href="/apple-touch-icon-60x60.png">
	<link rel="apple-touch-icon" sizes="72x72" href="/apple-touch-icon-72x72.png">
	<link rel="apple-touch-icon" sizes="76x76" href="/apple-touch-icon-76x76.png">
	<link rel="apple-touch-icon" sizes="114x114" href="/apple-touch-icon-114x114.png">
	<link rel="apple-touch-icon" sizes="120x120" href="/apple-touch-icon-120x120.png">
	<link rel="apple-touch-icon" sizes="144x144" href="/apple-touch-icon-144x144.png">
	<link rel="apple-touch-icon" sizes="152x152" href="/apple-touch-icon-152x152.png">
	<link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon-180x180.png">
	<link rel="icon" type="image/png" href="/favicon-32x32.png" sizes="32x32">
	<link rel="icon" type="image/png" href="/android-chrome-192x192.png" sizes="192x192">
	<link rel="icon" type="image/png" href="/favicon-96x96.png" sizes="96x96">
	<link rel="icon" type="image/png" href="/favicon-16x16.png" sizes="16x16">
	<link rel="manifest" href="/manifest.json">
	<meta name="msapplication-TileColor" content="#ffffff">
	<meta name="msapplication-TileImage" content="/mstile-144x144.png">
	<meta name="theme-color" content="#ffffff">
</head>
<body>
	<!-- HEADER SECTION -->
	<div class="header-section">

		<!-- TOPBAR SECTION -->
		<nav class = "top-bar important-class" data-topbar role="navigation">


			<!-- TITLE AREA & LOGO -->
			<ul class="title-area">
				<li class="name">
					<a href="index.html">
						<img src="img/WavoDyne_Logo.jpg" alt="WavoDyne Therapeutics" id="logo-image">
					</a>
				</li>
				<li class="toggle-topbar menu-icon"><a href="#"><span>menu</span></a></li>
			</ul> <!-- END TITLE AREA & LOGO -->

			<section class = "top-bar-section">
				<ul class ="right">
					<li class ="has-dropdown">
						<a href="about.html"> About Us </a>
						<ul class = "dropdown">
							<li> <a href="about.html#company_overview"> Company Overview </a></li>
							<li> <a href="about.html#leadership_team"> Leadership Team </a> </li>
							<li> <a href="about.html#scientific_board"> Scientific Advisory Board </a> </li>
							<li> <a href="about.html#board_of_directors"> Board of Directors </a> </li>
						</ul>
					</li>
					<li class ="has-dropdown">
						<a href="research.html"> Research and Development </a>
						<ul class = "dropdown">
							<li> <a href="research.html#research_and_development"> Research and Development </a></li>
							<li> <a href="research.html#neurodegenerative_disease"> Neurodegenerative Disease </a> </li>
							<li> <a href="research.html#therapeutic_approaches"> Therapeutic Approaches </a> </li>
							<li> <a href="research.html#product_pipeline"> Product Pipeline </a> </li>
							<li> <a href="research.html#intellectual_property"> Intellectual Property </a> </li>
							<li> <a href="research.html#collaborations"> Collaborations </a> </li>
						</ul>
					</li>
					<li class ="has-dropdown">
						<a href="news.html"> News &amp; Events </a>
						<ul class = "dropdown">
							<li> <a href="news.html#press_releases"> Press Releases </a></li>
							<li> <a href="news.html#scientific_publications"> Scientific Publications </a></li>
							<li> <a href="news.html#research_funding"> Research Funding </a></li>
							<li> <a href="news.html#resource-section"> Resources </a></li>
						</ul>
					</li>
					<li class ="has-dropdown">
						<a href="contact.html"> Work at WDT </a>
						<ul class = "dropdown">
							<li> <a href="contact.html#culture"> Culture </a> </li>
							<li> <a href="contact.html#positions_available"> Positions Available </a> </li>
							<li> <a href="contact.html#contact"> Contact Us </a></li>
						</li>
					</ul>
				</ul>
			</section>
		</nav> <!-- END TOPBAR SECTION -->
	</div> <!-- END HEADER SECTION -->

	<!-- CONTENT FILL WHEN SCROLL = 0 -->
	<div class="header-fill"></div>

	<!-- CONTENT SECTION -->
	<div class="row content-section">
		<div class="news-main-content">

			<!-- PARALLAX SECTION -->
			<div class = "row collapse" id ="parallax-otherpage">
				<div class="full-width-photos">
					<div class = "header-pic">
						<img data-interchange="[img/news.jpg, (default)], [img/news_small.jpg, (small-only)]" alt = "WavoDyne Logo">
						<noscript><img src="img/news.jpg" alt = "WavoDyne Therapeutics"></noscript>
					</div>
				</div>
				<div class = "small-12 columns text-center">
					<div class = "text-overlay">
						<h1> PUBLICATIONS BY OUR INDUSTRY EXPERTS </h1>
					</div>
				</div>
			</div>
			<!-- END PARALLAX SECTION -->


			<section id="press_releases" class="first">
				<div class = "row with_padding">

					<div class = "small-12 columns text-center">
						<h1 class = "section-header">
							Special Events
						</h1> 
												<p class ="paddingtop text-left">
						</p>
					</div>


					<div class ="small-12 columns text-left" id="info">
						<p>
						In attendance at the <a href="http://isnv.org/sd15/"> 13th International Symposium on NeuroVirology and 2015 Conference on HIV in the Nervous System </a> on June 4-6, 2015, in San Diego, CA. <br/> <br/>
						 
						Dr. Handy Gelbard is delivering the Special Lecture of 2015 Translational Research in NeuroVirology Lectureship, titled as "Inhibition of Mixed Lineage Kinases As A Disease Modifying Strategy for HAND: An Unusually Narrow Path For Patents".  The Translational Research in NeuroVirology Lectureship was developed to recognize the contributions of established investigators who study viral infections of the CNS and strive to translate their basic scientific discoveries into clinical applications and ultimately into public health improvements. This year will mark the inauguration of Translational Research in NeuroVirology Lectureship.<br/> <br/>
						 
						Dr. Gelbard’ talk will focus on the historical reasons for investigating the mixed lineage kinases (MLKs) as targets for therapeutic development of new agents that have the potential to modify the disease course of  HIV-1 associated neurocognitive disorders.  Additionally, the talk will briefly discuss the relationships between a target cell such as a neuron and an immune effector cell from the perspective of MLK signaling.  The talk will touch upon the considerable hurdles that exist in shepherding a new small molecule toward a commercial path with the goal of creating a new therapy.  Finally, the talk will discuss next steps in identifying other cell types impacted by loss of homeostasis between themselves and immune effector cells, as well as additional targets in the kinome with disease modifying potential.<br/> <br/>
						</p>
					</div>


					<div class = "small-12 columns text-center">
						<h1 class = "section-header">
							Press Releases
						</h1> 
					</div>
					<div class ="small-12 columns text-left" id="info">
						<p class ="paddingtop text-left">
						</p>
							<a href="http://www.rochestercitynewspaper.com/rochester/ur-drug-may-improve-memory/Content?oid=2543163">
								<p> <em> (May 20, 2015) </em> </p>
								<h4> UR Drug May Improve Memory</h4>
							</a>
							<a href="http://www.biospace.com/News/day-in-the-life-of-a-ceo-in-a-pharma-startupjim/376500">
								<p> <em> (May 15, 2015) </em> </p>
								<h4> Day in the Life of a CEO in a Pharma Start Up - Jim New</h4>
							</a>
							<a href="WavoDyne_RBJ_5-15-15.pdf">
								<p> <em> (May 15, 2015) </em> </p>
								<h4> Startup Developing a Drug in a Key Market </h4>
							</a>
							<a href="http://www.urmc.rochester.edu/news/story/index.cfm?id=4306">
								<p> <em> (April 30, 2015) </em> </p>
								<h4> URMC Start-up Takes Aim at Memory and Cognitive Problems</h4>
							</a>
							<a href="http://www.urmc.rochester.edu/news/story/index.cfm?id=4146">
								<p> <em>(August 28, 2014)</em> </p>
								<h4> Researchers Receive $3.4 million to Study Experimental Drug Combination in HIV</h4>
							</a>
					</div>
				</div>
			</section>

			<div class = "row with_padding">
				<section id="scientific_publications">
					<div class = "small-12 columns text-center">
						<h1 class = "section-header">
							Scientific Publications
						</h1> 
					</div>
					<div class ="small-12 medium-10 columns small-centered text-justify">
						<h3 class="subheader text-center">
							Dr. Harris Gelbard
							<p> <em>Selected Related Publications </em><p>
							</h3>
							<ul class = "no-bullet">
								<strong> 2015 </strong> <br/>
								<li>Puccini, JM, Marker, DF, Fitzgerald, T, Barbieri, J, Kim, CS, Miller-Rhodes, P, Lu, S-M, Dewhurst, S and HA Gelbard.  LRRK2 Modulates Neuroinflammation and Neurotoxicity in Models of HIV-1 Associated Neurocognitive Disorders. J Neurosci. 2015 Apr 1;35(13):5271-83. doi: 10.1523/JNEUROSCI.0650-14.2015  </li>
								<strong> 2014 </strong> <br/>
								<li>Boska, MD, Dash, PK, Knibbe, J, Epstein, AA, Akhter, SP, Fields, N, High, R, Makarov, E, Bonasera, S, Gelbard, HA, Poluetkova, LY, Gendelman, HE and S Gorantla.  Associations between brain microstructures, metabolites and cognitive deficits during chronic HIV-1 infection of humanized mice.  Mol. Neurodegen. 2014 Dec 18;9:58. doi: 10.1186/1750-1326-9-58.</li>
								<li> Gendelman HE, Gelbard HA.  Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders.  Curr Opin HIV AIDS. 2014 Nov;9(6):585-90. doi: 10.1097/COH.0000000000000111.  PMID: 25226025 </li>
								<strong> 2013 </strong> <br/>
								<li> Tremblay MÈ, Marker DF, Puccini JM, Muly EC, Lu SM, and Gelbard HA. Ultrastructure of microglia-synapse interactions in the HIV-1 Tat-injected murine central nervous system. Commun Integr Biol. 2013 Nov 1;6(6):e27670. doi: 10.4161/cib.27670. Epub 2013 Dec 31. PMID: 24563721.</li>
								<li>Marker DF, Tremblay M-È, Puccini JM, Barbieri J, Gantz Marker MA, Loweth CJ, Muly EC, Lu S-M, Goodfellow VS, Dewhurst S and Gelbard HA.  The new small molecule mixed lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of HIV associated neurocognitive disorders. J. Neurosci. 2013 Jun 12;33(24):9998-10010. PMID: 23761895.  SciBX (Nature) still pending. </li>
								<li> Ma Q, Gelbard HA, Maggirwar SB, Dewhurst S, Gendelman HE, Peterson DR, Difrancesco R, Hochreiter JS, Morse GD, Schifitto G. Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patients. J Neurovirol. 2013 Jun;19(3):254-60. doi: 10.1007/s13365-013-0172-z. Epub 2013 Jun 5. PMID: 23737347</li>
								<li> Goodfellow V, Loweth C, Ravula S, Wiemann T, Nguyen T, Xu Y, Todd D, Sheppard D, Pollack S, Polesskaya O, Marker D, Dewhurst S, and Gelbard HA.  Discovery, Synthesis and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3.  J. Med. Chem., 2013 Oct 24;56(20):8032-48. doi: 10.1021/jm401094t. Epub 2013 Oct 3. PMID: 24044867. </li>
								<strong> 2012 </strong> <br/>
								<li> Marker DF, Puccini JM, Mockus TE, Barbieri J, Lu SM, Gelbard HA.  LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein.  J Neuroinflammation. 2012 Nov 29;9(1):261. [Epub ahead of print] PMID: 23190742
								</li>
								<li>
									Dash PK, Gendelman HE, Roy U, Balkundi S, Alnouti Y, Mosley RL, Gelbard HA, McMillan J, Gorantla S, Poluektova LY.  Long-acting NanoART Elicits Potent antiretroviral and neuroprotective responses in HIV-1 Infected Humanized Mice.  AIDS. 2012 Nov 13;26(17):2135-44. doi: 10.1097/QAD.0b013e328357f5ad. PMID: 22824628
								</li>
								<strong> 2011 </strong> <br/>
								<li> Lu, SM, Tremblay, MÈ, King, IL, Qi, J, Reynolds, HM, Marker, DF, Varrone, JJ, Majewska, AK, Dewhurst, S, and Gelbard, HA.  HIV-1 Tat-Induced Microgliosis and Synaptic Damage via Interactions between Peripheral and Central Myeloid Cells.  PLoS One. 2011;6(9):e23915. Epub 2011 Sep 2. (Faculty of 1000, Rating 10/10)  PMID: 21912650. </li>
								<li> Perry, S W, Norman, JP, Barbieri, J, Brown, EB and HA Gelbard.  Mitochondrial membrane potential probes and the proton gradient: a practical usage guide.  Biotechniques. (February 2011) 50:98-115 (most frequently viewed article of 2011). PMID: 21486251. </li>
								<strong> 2010 </strong> <br/>
								<li> Gelbard HA, Dewhurst S, Maggirwar SB, Kiebala M, Polesskaya O, Gendelman HE. Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase. Therapeutics. 2010 Oct;7(4):392-8. PMID: 20880503</li>
							</ul>
						</div>

						<div class ="small-12 medium-10 columns small-centered text-justify">
							<h3 class="subheader text-center">
								Recent Publications Relevant to WavoDyne R&amp;D Activities
							</h3>
							<p class ="paddingtop">
								Coming soon
							</p>
						</div>
					</section>
				</div>


				<div class = "row with_padding">
					<section id="research_funding">
						<div class = "small-12 columns text-center">
							<h1 class = "section-header">
								Research Funding
							</h1> 
						</div>
						<div class ="small-12 medium-10 columns text-left">
							<p class = "paddingtop text-left">
								<strong> Total Federal Research Funding (anticipated): </strong> <br/>
								Principal Investigator: $38.4 mm<br/>
								<br/>
								<strong> Total Federal Research Funding Received-to-date:</strong> <br/>
								Principal Investigator: $29.8 mm <br/>
								<br/>
								<br/>
								<a href = "WavoDyne_funding_summary.pdf"><i class="fa fa-paperclip fa-1x"></i> &nbsp; <em>View Full Funding Details </em></a>
							</p>
						</div>
					</section>
				</div>


				<div class = "row with_padding">
					<section id="resource-section">
						<div class = "small-12 columns text-center">
							<h1 class = "section-header">
								Resources
							</h1> 
						</div>
						<div class ="small-12 medium-10 columns text-left">
							<p class ="paddingtop">
								<p> <strong>Informational resources from around the web: </strong></p>
								<ul class = "no-bullet">
									<li>
										<a href="http://www.poz.com/"> POZ: Health, Life & HIV </a>
									</li>
									<li>
										<a href="http://www.grayingofaids.org/"> The Graying of AIDS </a>
									</li>
									<li>
										<a href="http://www.thewellproject.org/hiv-information/hiv-and-brain"> The Well Project: HIV-Associated Brain Problems </a>
									</li>
									<li>
										<a href="http://www.thebody.com/content/art54535.html"> The Complete HIV/AIDS Resource: HIV and the Brain </a>
									</li>
								</ul>
							</p>
						</div>
					</section>
				</div>




			</div>
		</div> <!-- END CONTENT SECTION -->

	<!-- FOOTER SECTION -->
	<div class="footer-section">
		<div class="row">
<!-- 			<div class = "small-12 columns text-center">
				<a href= "https://www.facebook.com/camberneuro"><i class="fa fa-facebook-square fa-1x"> </i></a>
				<a href= "https://www.linkedin.com/company/camber-neurotherapeutics"><i class="fa fa-linkedin-square fa-1x"> </i></a>
			</div> -->
			<div class="small-12 medium-4 large-4 columns small-text-center medium-text-left">
				<p> 
					<!-- <img src = "img/WavoDyne_Logo_white.png" alt ="WavoDyne Therapeutics logo"></img><br/> -->
					&copy; Copyright 2015 <br/>
					<small><em>Designed by <a href= "http://www.brianayers.me"> Brian Ayers</a></em></small>
				</p>
			</div>
			<div class = "small-12 medium-4 columns small-text-center">
				<p>Lennox Tech Enterprise Center<br/>
				150 Lucius Gordon Drive, Suite 100<br/>
				Rochester, NY 14586</p>
			</div>
			<div class="small-12 medium-4 large-4 columns small-text-center medium-text-right">
				<p> 
					<a href="mailto:info@wavodyne.com">info @ wavodyne.com</a><br/>
					ph: 954.632.6630<br/>
					fax: 954.452.4656
				</p>
			</div>
		</div>
	</div> <!-- END FOOTER SECTION -->
		<script src="bower_components/jquery/dist/jquery.min.js"></script>
		<script src="bower_components/foundation/js/foundation.min.js"></script>
		<script src="js/app.js"></script>
		<script src="js/init.js"></script>
	</body>
	</html>